The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ISHARES INC | CORE MSCI EMKT | 46434G103 | 144,874 | 2,953,000 | SH | SOLE | 2,953,000 | 0 | 0 | ||
DUOLINGO INC | CL A COM | 26603R106 | 52,725 | 602,233 | SH | SOLE | 602,233 | 0 | 0 | ||
NEUBASE THERAPEUTICS INC | COM | 64132K102 | 986 | 939,412 | SH | SOLE | 939,412 | 0 | 0 | ||
PREDICTIVE ONCOLOGY INC | COM NEW | 74039M200 | 85 | 207,144 | SH | SOLE | 207,144 | 0 | 0 | ||
VERA THERAPEUTICS INC | CL A | 92337R101 | 219 | 16,060 | SH | SOLE | 16,060 | 0 | 0 | ||
INNSUITES HOSPITALITY TR | SH BEN INT | 457919108 | 29 | 10,000 | SH | SOLE | 10,000 | 0 | 0 |